Differential expression of MOC-31, Hep Par 1, and N-cadherin in primary carcinoma and metastatic adenocarcinoma in the liver
Ahmed, M., Badary, F., Yassin, E., Mohammed, S., El-Attar, M. (2016). Differential expression of MOC-31, Hep Par 1, and N-cadherin in primary carcinoma and metastatic adenocarcinoma in the liver. EKB Journal Management System, 1(3), 54-60. doi: 10.4103/2357-0121.199354
Mohammed A. Ahmed; Fatma A. Badary; Etemad H. Yassin; Said A. Mohammed; Madiha M. El-Attar. "Differential expression of MOC-31, Hep Par 1, and N-cadherin in primary carcinoma and metastatic adenocarcinoma in the liver". EKB Journal Management System, 1, 3, 2016, 54-60. doi: 10.4103/2357-0121.199354
Ahmed, M., Badary, F., Yassin, E., Mohammed, S., El-Attar, M. (2016). 'Differential expression of MOC-31, Hep Par 1, and N-cadherin in primary carcinoma and metastatic adenocarcinoma in the liver', EKB Journal Management System, 1(3), pp. 54-60. doi: 10.4103/2357-0121.199354
Ahmed, M., Badary, F., Yassin, E., Mohammed, S., El-Attar, M. Differential expression of MOC-31, Hep Par 1, and N-cadherin in primary carcinoma and metastatic adenocarcinoma in the liver. EKB Journal Management System, 2016; 1(3): 54-60. doi: 10.4103/2357-0121.199354

Differential expression of MOC-31, Hep Par 1, and N-cadherin in primary carcinoma and metastatic adenocarcinoma in the liver

Journal of Current Medical Research and Practice
Volume 1, Issue 3, September 2016, Page 54-60  XML PDF (2.07 MB)
DOI: 10.4103/2357-0121.199354
View on SCiNiTO View on SCiNiTO
Authors
Mohammed A. Ahmed; Fatma A. Badary; Etemad H. Yassin; Said A. Mohammed; Madiha M. El-Attar
Abstract
Background
Immunohistochemistry plays a crucial role in the diagnosis of hepatocellular carcinoma (HCC) and in its distinction from other primary and metastatic neoplasms. In this study, we examined the expression of MOC-31 (Anti-epithelial cell adhesion molecule monoclonal antibody, clone number-31), hepatocyte paraffin 1 (Hep Par 1), and N-cadherin in primary carcinoma and metastatic adenocarcinoma (AC) in the liver.
Aim
The aim of this study was to evaluate the usefulness of MOC-31, Hep Par 1, and N-cadherin in the differential diagnosis of primary carcinoma and metastatic AC in the liver.
Materials and methods
The present study included 56 specimens from cases of primary and metastatic liver tumors, including 20 primary HCCs in the liver, five intrahepatic cholangiocarcinomas, and 31 metastatic ACs in the liver. They were studied to evaluate MOC-31, Hep Par 1, and N-cadherin expression using immunohistochemistry.
Results
The sensitivity of MOC-31 for AC in the studied group was 97.2%, whereas its specificity was 90%. The sensitivity of Hep Par 1 for HCC was 75%, whereas its specificity was 100%. The sensitivity of N-cadherin for primary liver carcinoma was 72%, whereas its specificity was 83.9%. Using the combination of the three antibodies, a final diagnosis could be established in 52 of 56 (92.9%) cases of studied group. In conclusion, a panel of these three antibodies can be helpful in the distinction between primary carcinoma and metastatic AC in the liver.
Keywords
Cholangiocarcinoma; Hepatocyte paraffin 1; Hepatocellular carcinoma; Immunohistochemistry; metastatic adenocarcinoma; MOC-31; N-Cadherin
Statistics
Article View: 51
PDF Download: 30